9:22 AM
Leo Group India
| ||
| Par Pharmaceutical Agrees to Be Bought by TPG Bloomberg Par Pharmaceutical Cos., a maker of generic drugs, agreed to be acquired for $1.9 billion by TPG Capital as the private-equity firm looks to gain from efforts to curtail health-care costs. See all stories on this topic » | ||
| Par Pharmaceutical to be Acquired for $1.84 Billion by TPG; Shares Up Wall Street Journal "We are excited for the opportunity to invest in Par, a leading generic pharmaceutical company that has a long track record of success via its focus on complex products and its strong, diversified product pipeline," said TPG partner Todd B. Sisitsky. See all stories on this topic » | ||
| TPG buying Par Pharmaceutical for about $1.84B Businessweek WOODCLIFF LAKE, N.J. (AP) — The generic drug maker Par Pharmaceutical Cos. has agreed to be acquired for about $1.84 billion in cash by an affiliate of private investment firm TPG. See all stories on this topic » | ||
| Par Pharmaceutical Companies Enters Into Definitive Agreement To Be ... MarketWatch (press release) WOODCLIFF LAKE, N.J., July 16, 2012 /PRNewswire via COMTEX/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) announced today that it has entered into a definitive merger agreement to be acquired by an affiliate of TPG in a transaction with an equity ... See all stories on this topic » | ||
| Par Pharmaceuticals announces it will be acquired for $1.8 billion The Star-Ledger - NJ.com Par's stock jumped $13.86, or 37.9 percent, to $50.44 in morning trading. See all stories on this topic » | ||
| TPG agrees to buy generic drugmaker Par for $1.9 billion Reuters India (Reuters) - Private equity firm TPG said on Monday it would acquire U.S.-based Par Pharmaceutical Cos Inc for $1.9 billion in the latest acquisition in the generic drug industry.The $50-a-share deal represents. See all stories on this topic » | ||
| Par Pharmaceutical agrees to be acquired by TPG affiliate for about $1.84B CanadianBusiness.com WOODCLIFF LAKE, N.J. - The generic drug maker Par Pharmaceutical Cos. has agreed to be acquired for about US$1.84 billion in cash by an affiliate of p. See all stories on this topic » | ||
| US HOT STOCKS: Human Genome Sciences, Par Pharmaceutical, Visa Wall Street Journal Par Pharmaceutical Cos. (PRX, $50.18, +$13.60, +37.19%) agreed to be acquired by private investment firm TPG for $1.84 billion in cash, a deal that comes after the specialty generic pharmaceutical company made a series of deals to boost its pipeline. See all stories on this topic » | ||
| Par Pharmaceutical To Be Taken Private By TPG In $1.9 Bln Deal RTT News Specialty pharmaceutical company Par Pharmaceutical Companies, Inc. (PRX) agreed Monday to be taken private by an affiliate of private equity firm TPG for $50.00 per share in an all-cash deal valued at $1. See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment